Bafna Pharmaceuticals Limited’s (BAFNAPH) Moving Averages Convergence Divergence (MACD) indicator is 21.31, suggesting Bafna Pharmaceuticals Limited is a Buy.
Bafna Pharmaceuticals Limited’s (BAFNAPH) 20-Day exponential moving average is 446.23, while Bafna Pharmaceuticals Limited’s (BAFNAPH) share price is ₹484.50, making it a Buy.
Bafna Pharmaceuticals Limited’s (BAFNAPH) 50-Day exponential moving average is 395.80, while Bafna Pharmaceuticals Limited’s (BAFNAPH) share price is ₹484.50, making it a Buy.
Bafna Pharmaceuticals Limited’s (BAFNAPH) 10-Day exponential moving average is 459.94, while Bafna Pharmaceuticals Limited’s (BAFNAPH) share price is ₹484.50, making it a Buy.
Bafna Pharmaceuticals Limited’s (BAFNAPH) 100-Day exponential moving average is 332.56, while Bafna Pharmaceuticals Limited’s (BAFNAPH) share price is ₹484.50, making it a Buy.
Bafna Pharmaceuticals Limited’s (BAFNAPH) stock price is ₹484.50 and Bafna Pharmaceuticals Limited’s (BAFNAPH) 50-day simple moving average is 387.99, creating a Buy signal.
Bafna Pharmaceuticals Limited’s (BAFNAPH) stock price is ₹484.50 and Bafna Pharmaceuticals Limited’s (BAFNAPH) 100-day simple moving average is 313.05, creating a Buy signal.
Bafna Pharmaceuticals Limited’s (BAFNAPH) stock price is ₹484.50 and Bafna Pharmaceuticals Limited’s (BAFNAPH) 200-day simple moving average is 220.77, creating a Buy signal.